Search Results

There are 58027 results for: content related to: Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden

  1. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer

    BJU International

    Volume 93, Issue 7, May 2004, Pages: 970–974, O.L. Ozdal, A.G. Aprikian, L.R. Bégin, H. Behlouli and S. Tanguay

    Article first published online : 5 MAY 2004, DOI: 10.1111/j.1464-410X.2003.04762.x

  2. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection

    BJU International

    Volume 96, Issue 4, September 2005, Pages: 521–527, Carsten Stephan, Klaus Jung, Antoninus Soosaipillai, George M. Yousef, Henning Cammann, Hellmuth Meyer, Chuanliang Xu and Eleftherios P. Diamandis

    Article first published online : 11 AUG 2005, DOI: 10.1111/j.1464-410X.2005.05677.x

  3. A comparison of six commercial assays for total and free prostate specific antigen (PSA): the predictive value of the ratio of free to total PSA

    BJU International

    Volume 85, Issue 6, April 2000, Pages: 686–689, D. Patel, P.A.E. White and A. Milford Ward

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.2000.00526.x

  4. From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

    BJU International

    Volume 112, Issue 6, October 2013, Pages: 717–728, Satoshi Hori, Jean-Sebastien Blanchet and John McLoughlin

    Article first published online : 3 JUL 2012, DOI: 10.1111/j.1464-410X.2012.11329.x

  5. You have full text access to this OnlineOpen article
    The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL

    Cancer

    Volume 104, Issue 5, 1 September 2005, Pages: 993–1003, Carsten Stephan, Greta Stroebel, Marc Heinau, Andre Lenz, Andreas Roemer, Michael Lein, Dietmar Schnorr, Stefan A. Loening and Klaus Jung

    Article first published online : 8 JUL 2005, DOI: 10.1002/cncr.21267

  6. You have full text access to this OnlineOpen article
    An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: Results of a 5-year investigation

    International Journal of Cancer

    Volume 99, Issue 3, 20 May 2002, Pages: 466–473, Carsten Stephan, Klaus Jung, Henning Cammann, Birgit Vogel, Brigitte Brux, Glen Kristiansen, Birgit Rudolph, Steffen Hauptmann, Michael Lein, Dietmar Schnorr, Pranav Sinha and Stefan A. Loening

    Article first published online : 19 MAR 2002, DOI: 10.1002/ijc.10370

  7. You have full text access to this OnlineOpen article
    Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 μg/L: Are they useful tools for early detection and screening of prostate cancer?

    International Journal of Cancer

    Volume 93, Issue 5, 1 September 2001, Pages: 759–765, Klaus Jung, Carsten Stephan, Ulrike Elgeti, Michael Lein, Brigitte Brux, Glen Kristiansen, Birgit Rudolph, Steffen Hauptmann, Dietmar Schnorr, Stefan A. Loening and Pranav Sinha

    Article first published online : 12 JUN 2001, DOI: 10.1002/ijc.1393

  8. You have free access to this content
    Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL

    International Journal of Urology

    Volume 10, Issue 4, April 2003, Pages: 201–206, TAKATSUGU OKEGAWA, MANAMI KINJO, MASAYA OHTA, ICHIRO MIURA, SHIGEO HORIE, KIKUO NUTAHARA and EIJI HIGASHIHARA

    Article first published online : 28 MAR 2003, DOI: 10.1046/j.0919-8172.2003.00605.x

  9. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics

    BJU International

    Volume 102, Issue 7, October 2008, Pages: 799–805, Carsten Stephan, Henning Cammann, Hellmuth-Alexander Meyer, Christian Müller, Serdar Deger, Michael Lein and Klaus Jung

    Article first published online : 3 JUN 2008, DOI: 10.1111/j.1464-410X.2008.07765.x

  10. The prognostic value of different forms of prostate specific antigen and their ratios in patients with prostate cancer

    BJU International

    Volume 84, Issue 9, December 1999, Pages: 1021–1027, Björk, Lilja and Christensson

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.1999.00345.x

  11. Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6–4.0 ng/mL range of total PSA

    BJU International

    Volume 94, Issue 1, July 2004, Pages: 47–50, J. Kellogg Parsons, Michael K. Brawer, Carol D. Cheli, Alan W. Partin and Robert Djavan

    Article first published online : 24 JUN 2004, DOI: 10.1111/j.1464-410X.2004.04899.x

  12. Comparative Analysis of the Role of Prostate Specific Antigen Parameters in Clinical Practice

    The Prostate Journal

    Volume 2, Issue 4, December 2000, Pages: 205–210, Naing N. K. Lynn, Gerald N. Collins, Kyriakos Alexandrou, Stephen C. W. Brown, Peter J. C. Brooman and Patrick H O'reilly

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1525-1411.2000.24009.x

  13. You have free access to this content
    Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer

    International Journal of Urology

    Volume 13, Issue 3, March 2006, Pages: 238–243, CARSTEN STEPHAN, KLAUS JUNG, TERUKAZU NAKAMURA, GEORGE M YOUSEF, GLEN KRISTIANSEN and ELEFTHERIOS P DIAMANDIS

    Article first published online : 4 APR 2006, DOI: 10.1111/j.1442-2042.2006.01276.x

  14. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population

    British Journal of Urology

    Volume 82, Issue 2, August 1998, Pages: 231–236, Lein, Koenig, Jung, Mcgovern, Skates, Schnorr and Loening

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1464-410X.1998.00723.x

  15. Changes in molecular forms of prostate-specific antigen during treatment with finasteride

    BJU International

    Volume 90, Issue 7, November 2002, Pages: 672–677, F. España, M. Martínez, M. Royo, A. Estellés, J.M. Alapont, S. Navarro, J. Aznar and J.F. Jiménez-Cruz

    Article first published online : 31 OCT 2002, DOI: 10.1046/j.1464-410X.2002.03002.x

  16. You have full text access to this OnlineOpen article
    Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy

    International Journal of Cancer

    Volume 120, Issue 7, 1 April 2007, Pages: 1499–1504, Thomas Steuber, Andrew Vickers, Alexander Haese, Michael W. Kattan, James A. Eastham, Peter T. Scardino, Hartwig Huland and Hans Lilja

    Article first published online : 4 JAN 2007, DOI: 10.1002/ijc.22427

  17. The clinical impact of different assays for prostate specific antigen

    BJU International

    Volume 86, Issue 5, September 2000, Pages: 590–597, A. Semjonow, G. De Angelis, F. Oberpenning, H.-P. Schmid, B. Brandt and L. Hertle

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.2000.00858.x

  18. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy

    BJU International

    Volume 109, Issue 11, June 2012, Pages: 1627–1635, Marco Auprich, Herbert Augustin, Lars Budäus, Luis Kluth, Sebastian Mannweiler, Shahrokh F. Shariat, Margit Fisch, Markus Graefen, Karl Pummer and Felix K.-H. Chun

    Article first published online : 21 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10584.x

  19. You have free access to this content
    Use of various combinations of free, complexed and total prostate-specific antigen levels as predictors of the pathologic stage of prostate cancer

    International Journal of Urology

    Volume 8, Issue 8, August 2001, Pages: 438–443, Takatsugu Okegawa, Haruhisa Noda, Masaya Ohta, Moriaki Kato, Kikuo Nutahara and Eiji Higashihara

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1442-2042.2001.00351.x

  20. The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1–10.0 ng/mL

    BJU International

    Volume 85, Issue 6, April 2000, Pages: 708–714, T. Okegawa, M. Kinjo, K. Watanabe, H. Noda, M. Kato, A. Miyata, A. Murata, M. Yoshii, K. Nutahara and E. Higashihara

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1464-410x.2000.00602.x